ADDPI 2020_05 INADA vs Anshula Rao

In July 2020 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the cricket player Anshula Rao after her sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone).

After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).

The Athlete denied the intentional use of the substance and could not explain how the substance had entered her system. She argued that the 4 month delay in the Notification prevented her to find the source of the Nandrolone.

The Athlete disputed the irregularities she had established regarding the A sample documentation package, the chain of custody and the sample collection procedure. Further she complained that she could not perform analysis of the B sample because of the costs (€ 1500,-), In additions she could not attend the opening op de B sample in the Ghent Lab whereas there were the COVID-19 restrictions to travel.

The Panel considered the Athletes assertions and concludes that she failed to demonstrate any departure of the ISTI regarding the documentation package, the chain of custody and the sample collection procedure. The Panel also finds that there had been no unreasonable delays in the Ghent Lab before Notification.

The Panel agrees that the intended analysis of the Athlete's B sample was prevented because of the costs and is displeased that INADA has no provisions for financial assistance in this matter.

Finally The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that the she committed an anti-doping rule violation. The Panel deems that she failed to explain how the substance entered her system and concludes that she had used the substance knowingly and intentionally.

Therefore the Anti-Doping Discipinary Panel of India decides on 31 May 2021 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension.

Original document

Parameters

Legal Source
National Decisions
Date
31 May 2021
Arbitrator
Chengappa, Rana
Kanth, Gaurang
Kumar, Akhil
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
ADRV Notice
Case law / jurisprudence
Intent
International Standard for Testing and Investigations (ISTI)
Substantial delay / lapsed time limit
Sport/IFs
Cricket (ICC) - International Cricket Council
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
Ghent, Belgium: DoCoLab Universiteit Gent-UGent
Analytical aspects
Mass spectrometry analysis
Doping classes
S1. Anabolic Agents
Substances
19-norandrosterone
Nandrolone (19-nortestosterone)
Various
Chain of custody
Doping control
Sample collection procedure
Document type
Pdf file
Date generated
11 November 2021
Date of last modification
23 June 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin